Phase 1 Study to Determine the Efficacy of Using Far Infrared Radiation for Multiple Sclerosis.

Status unknownPhase 1MS (type not specified)NCT00674934

What it found

No results found

We found no results in the registry or in papers.

What was tested

Treatment tested

  • Far Infrared Radiation (5μm to 20μm wavelength)

What it measured

Main measures

  • Treatment of MS

    2 years

Other measures (1)

  • Rehabilitation of MS Patients

    2 Years

Who could take part

MS (type not specified)

Show the full criteria

Inclusion criteria

* Patients with MS

Exclusion criteria

* None

As registered. Criteria can change, so ask the trial team or your neurologist.

About this trial

In the sponsor's words

Multiple sclerosis (abbreviated MS) is an autoimmune condition in which the immune system attacks the central nervous system (CNS), leading to demyelination. This study will investigate the use of far infrared radiation for MS control, management and treatment.

Loading reviews and guidelines…

History

    1. Started

      May 2008

    2. Main results due

      May 2010

    3. Finished

      Jun 2010

    Assembled by software from public sources.